2024 marked 10 years since we launched Open Philanthropy. We spent our first decade learning (about grantmaking, cause selection, and the history of philanthropy), and growing our team and expertise to be able to effectively deploy billions of dollars from Good Ventures, our main funder. Our early grants — and some grantees we’ve helped get started — are now old enough that we can see material signs of our impact in the world.
Editor’s note: This article was published under our former name, Open Philanthropy. In 2024, grantees in Open Philanthropy’s Global Health and Wellbeing (GHW) portfolio made progress toward developing a next-generation malaria vaccine, successfully advocated for U.K. retailers to adopt a new welfare standard that we expect to improve conditions...
From driving pedicabs in Austin to conducting mathematics research in Sydney to practicing law at traditional firms, our team members have followed diverse paths to their current roles.
Editor’s note: This article was published under our former name, Open Philanthropy. Some content may be outdated. You can see our latest writing here. At Open Philanthropy, we spend a lot of time thinking about how to do the most good through our grantmaking. Many of us are also passionate...
We spotlight five grantees whose work exemplifies our approach to hits-based giving in scientific research. These examples illustrate different aspects of our science funding strategy and represent some of the project types we aim to support.
Editor’s note: This article was published under our former name, Open Philanthropy. Some content may be outdated. You can see our latest writing here. As we enter the holiday giving season, we’re continuing our tradition of sharing a list of giving opportunities suggested by Open Philanthropy program staff. Notes on...
This piece compiles some of the most notable writings on AI by current and former staff over the last decade. They are not intended to represent our “institutional view” on AI. No such view exists — our program staff, as well as our grantees, often disagree with each other.
In October, our longtime grantee David Baker won the Nobel Prize in Chemistry for groundbreaking work in protein design. We wanted to take the opportunity to highlight his work and some of its practical applications, such as enabling better vaccines.
Rossa O'Keeffe-O'Donovan, Rafael Latham-Proença and Oliver Kim
/
Announcements
/
October 16, 2024
Editor’s note: This article was published under our former name, Open Philanthropy. Some content may be outdated. You can see our latest writing here. This is a high-level summary of our approach to launching a program focused on economic growth in low- and middle-income countries (LMICs) and not a medium...
